The efforts of even the most productive research teams can be wasted if the knowledge they gain is not effectively mobilised. CCfV and its partners have already established tremendous expertise in the evaluation of vaccines and other interventions as well as social science and ethics experts that can assist in effective knowledge mobilisation linking closely with the community at all stages of the research endeavor. These links, together with established international collaborations, local facilities for human trials, and proven industry partnerships ensure that the research done by I3V will make a difference.

Read More

‘Viroceuticals’ describes the use of viruses to harness the power of the human immune system to develop new preventative and therapeutic treatments. These include vaccines, antiviral drugs and cancer-fighting oncolytic viruses. By leveraging new discoveries of virus biology and human immune responses to infection, I3V researchers are developing the next generation of viroceuticals.

Read More

I3V researchers seek to harness the power of the human immune system to create new immunotherapies to combat cancer and chronic inflammatory diseases like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Rather than simply reducing inflammation, we seek to train immune responses to resolve these disease processes.

Read More